Dive into a highly practical program benchmarking in vivo, in vitro, and in silico toxicology models, with real-world case studies on NAM validation, regulatory strategy, dose selection, and human-relevant translation.
Position your solutions at the center of industry decision-making as pharma and biotech actively evaluate next-generation CRO services, NAM platforms, AI tools, and translational models to reduce risk and accelerate IND success.
Connect with investigative, translational, preclinical, and regulatory toxicologists from the top biopharma companies through focused workshops, panels, and networking designed to spark meaningful scientific and commercial conversations.